Multimeric Disintegrin Protein Polymer Fusions That Target Tumor Vasculature

[Image: see text] Recombinant protein therapeutics have increased in number and frequency since the introduction of human insulin, 25 years ago. Presently, proteins and peptides are commonly used in the clinic. However, the incorporation of peptides into clinically approved nanomedicines has been li...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Janib, Siti M., Gustafson, Joshua A., Minea, Radu O., Swenson, Stephen D., Liu, Shuanglong, Pastuszka, Martha K., Lock, Lye Lin, Cui, Honggang, Markland, Francis S., Conti, Peter S., Li, Zibo, MacKay, J. Andrew
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Chemical Society 2014
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4098058/
https://ncbi.nlm.nih.gov/pubmed/24871936
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/bm401622y
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi